Sankalp India Foundation's programs have often been designed with focus on maximizing benefit to the end recipient. Our Rakta Kranti program however is a little different. Here the focus is the donor the selfless, heroic blood donor. Through the nearly 950 blood donation drives and approximately 83000 units of blood collected, we have focused only on quality in drive execution with maximum compliance to standards.
World Health Organization (WHO) has been planning and adopting several measures to ensure that equity of care is never compromised or ignored in the delivery of healthcare.
We were happy to have the visit of eminent global experts of transplantation for Sickle Cell Disease, Dr. Francoise Bernaudin and Dr. Mathieu Kuentz from the Referral Center for Sickle Cell Disease, CHIC, Creteil Hospital and the DrepaGreffe Association France from 27th February to 1st March 2017.
Sukrana Two years back, in the first few day of March, Sukrana received her bone marrow transplantation at South East Asia Institute of Thalaasemia Jaipur. It was the first transplant supported by Sankalp India Foundation and the beginning of a journey towards cure from the disease.
A clinical trial is an important element of research in the field of medicine and science. Before any treatment protocol, or medicine or any practice related to the patient is brought into mainstream practice, it is essential that the trials have proved it's impact.
The meeting was organized with the intention of developing synergy between the various centers involved in the transplantation for thalassemia as part of the Sankalp-Cure2Children Thalassemia BMT Network. The following organizations were represented in the meeting: